Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib.
Saved in:
| Title: | Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib. |
|---|---|
| Authors: | Qin, Ya-Zhen1 (AUTHOR), Jiang, Qian1 (AUTHOR), Lai, Yue-Yun1 (AUTHOR), Jiang, Hao1 (AUTHOR), Shi, Hong-Xia1 (AUTHOR), Zhao, Xiao-Su1 (AUTHOR), Liu, Yan-Rong1 (AUTHOR), Huang, Xiao-Jun1,2 (AUTHOR) xjhrm@medmail.com.cn |
| Source: | Leukemia & Lymphoma. Jun2017, Vol. 58 Issue 6, p1384-1393. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 121663384 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Qin%2C+Ya-Zhen%22">Qin, Ya-Zhen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Qian%22">Jiang, Qian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lai%2C+Yue-Yun%22">Lai, Yue-Yun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Hao%22">Jiang, Hao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Hong-Xia%22">Shi, Hong-Xia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Xiao-Su%22">Zhao, Xiao-Su</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yan-Rong%22">Liu, Yan-Rong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Xiao-Jun%22">Huang, Xiao-Jun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> xjhrm@medmail.com.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jun2017, Vol. 58 Issue 6, p1384-1393. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=121663384 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2016.1239260 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1384 Titles: – TitleFull: Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Qin, Ya-Zhen – PersonEntity: Name: NameFull: Jiang, Qian – PersonEntity: Name: NameFull: Lai, Yue-Yun – PersonEntity: Name: NameFull: Jiang, Hao – PersonEntity: Name: NameFull: Shi, Hong-Xia – PersonEntity: Name: NameFull: Zhao, Xiao-Su – PersonEntity: Name: NameFull: Liu, Yan-Rong – PersonEntity: Name: NameFull: Huang, Xiao-Jun IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 58 – Type: issue Value: 6 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |
